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Background. The characteristics, determinants, and potential contribution to transmission of asymptomatic
cases of respiratory syncytial virus (RSV) infection have not been well described.
Methods. A cohort of 47 households (493 individuals) in coastal Kenya was recruited and followed for a 26-week
period spanning a complete RSV season. Nasopharyngeal swab specimens were requested weekly, during the ﬁrst
4 weeks, and twice weekly thereafter from all household members, regardless of illness status. The samples were
screened for a range of respiratory viruses by multiplex real-time polymerase chain reaction.
Results. Tests on 16 928 samples yielded 205 RSV infection episodes in 179 individuals (37.1%) from 40 differ-
ent households. Eighty-six episodes (42.0%) were asymptomatic. Factors independently associated with an increased
risk of asymptomatic RSV infection episodes were higher age, shorter duration of infection, bigger household size,
lower peak viral load, absence of concurrent RSV infections within the household, infection by RSV group B, and no
prior human rhinovirus infections. The propensity of RSV spread in households was dependent on symptom status
and amount (duration and load) of virus shed.
Conclusions. While asymptomatic RSV was less likely to spread, the high frequency of symptomless RSV infection
episodes highlights a potentially important role of asymptomatic infections in the community transmission of RSV.
Keywords. respiratory syncytial virus (RSV); asymptomatic; transmission; households; Kenya.
Determination of the incidence of infection is key in
studying respiratory disease epidemiology and trans-
mission patterns and, hence, in designing appropriate
interventions. However, most studies rely on the clini-
cal presentation of the illness to initiate diagnostic
procedures [1]. Unrecognized asymptomatic infections
are likely to form important links in transmission of
respiratory viruses in the community. Few community
studies have attempted diagnosis of respiratory syncy-
tial virus (RSV) infection irrespective of symptoms
[2–4]. Consequently, estimates of the proportion of
RSV infections that are without symptoms are limited,
and their contribution to transmission patterns at the
community level has not been characterized. This
may be especially important in older children and
adults, in whom virus shedding (both amount and du-
ration) is less than for younger individuals [5, 6]. These
issues ﬁnd focus in this article.
To effectively identify infections, as opposed to just
disease, intensive surveillance is required. This involves
collecting samples at intervals of the order of the infec-
tion generation time (ie, days for most respiratory virus-
es), regardless of illness status, and using highly sensitive
diagnostic procedures. Additionally, the procedures must
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be acceptable to the local population, to maintain compliance
over a sufﬁcient period of study. The current work analyses
data from a study conducted in rural coastal Kenya that con-
formed to these requirements. The primary objective was to iden-
tify who infects whom and, in particular, who infects young
infants in rural households [7]. The current analysis aimed to
estimate the prevalence of asymptomatic RSV infections, identify
predictors of asymptomatic episodes, and assess the role of
asymptomatic cases in the spread of RSV in households.
MATERIALS AND METHODS
The study was undertaken in rural coastal Kenya within the
Kiliﬁ Health and Demographic Surveillance System [8]. A co-
hort of 47 households with young infants and other members
(n=493 individuals) were prospectively sampled, regardless of
their illness status, weekly over the ﬁrst 4 weeks and thereafter
twice weekly over 1 complete RSV season (December 2009
through June 2010) that lasted 26 weeks, as has been described
previously [5, 7]. A household was deﬁned as a group of indi-
viduals living in the same compound and with communal
cooking arrangements. The RSV season was identiﬁed from
surveillance conducted by the local county hospital and was
deﬁned as a period in which at least 2 RSV cases were detected
per week in each of the 2 contiguous weeks and continued as
long as these conditions were met [9].During every home visit,
trained ﬁeld assistants recorded the presence of respiratory
symptoms (ie, cough, runny or blocked nose, or difﬁculty in
breathing). The presence of 1 or more of these symptoms de-
ﬁned acute respiratory disease (ARD). Nasopharyngeal swab
specimens were collected and screened for RSV (groups A
and B), human rhinovirus (hRV), human coronavirus (hCoV-
OC43, NL63, and 229E), and adenovirus (AdV), using multi-
plex real-time polymerase chain reaction (PCR) [10]. For each
test target, a cycle threshold (Ct) value of ≤35 was considered
positive for virus [11].
Statistical Analysis
All data analyses were done using Stata, version 11.2 (Stata,
College Station, Texas). An RSV infection episode was assigned
to an individual for whom there was 1 or more RSV-positive
sample, with no 2 consecutive positive samples separated by
>14 days. The episode period lasted from the day of the ﬁrst
positive sample through the last day within that episode.
The midpoint duration of shedding calculated in a previous
publication [5], which assumed that RSV shedding begins mid-
way between the time of the preceding PCR-negative sample
and ﬁrst PCR-positive sample and ends midway between last
positive and the next negative specimen of the episode, was
used in this study. Episodes whose ﬁrst sample was positive
for both RSV group A and B counted as 1 infection episode
and were assigned to either RSV group in the ﬁnal analysis,
depending on the RSV group with the higher peak viral load
or longer virus shedding duration. An asymptomatic case was
deﬁned as the absence of any ARD symptoms in the course
of the RSV infection episode. The timing of the start of symp-
toms was deﬁned for every episode. The ﬁrst person(s) in the
household to acquire RSV infection, based on the date of sam-
ple collection, was referred to as the index case(s). A household
RSV outbreak was identiﬁed when at least 1 other infection oc-
curred during or within 14 days from the end of the infection
episode of an index case in the same household. The outbreaks
were conﬁrmed to be of the same strain by comparing partial G
gene sequences of the selected virus-positive specimens in the
household [7]. The prevalence of asymptomatic RSV episodes
was estimated and stratiﬁed by a number of characteristics, in-
cluding age, infecting RSV group, sex, minimum Ct value dur-
ing the episode, detection of other respiratory viruses before
and during the episode, and presence of concurrent RSV infec-
tion in the same household. The minimum Ct value over the
RSV episode was used as a proxy measure for the peak viral
load, on the assumption that Ct values are inversely proportion-
al to the quantity of speciﬁc viral nucleic acid in the sample [12].
The Ct values were also converted to arbitrary units (AU),
where 1 unit increment was equivalent to a change of 3.3 Ct
units and estimated to be a 10-fold increase in viral load [13].
Multilevel mixed-effects logistic regression methods were used
to identify predictors for asymptomatic RSV infections and for
within-household spread of index infections. Participants were
nested within households, deﬁning the grouping structure in
the ﬁnal multilevel model. A P value of ≤.05 was considered
statistically signiﬁcant.
Ethical Considerations
The KEMRI Ethical Review Committee in Kenya and Universi-
ty of Warwick Biomedical Research Ethical Committee in the
United Kingdom approved the study. Verbal assent was sought
from participants aged <18 years, and written informed consent
obtained from all participants or their parents/guardians.
RESULTS
Baseline Characteristics and Sampling
The median age of the 493 study participants was 11.0 years
(range, 2 weeks to 92 years), with 11.4%, 28.4%, 62.1%, and
91.3% aged <1, <5, <15, and <40 years of age, respectively, at
the start of the study. A total of 221 (44.8%) were male. The me-
dian size of the 47 households was 8 members (range, 4–37
members). Additional baseline characteristics are shown in
Supplementary Table 1 and elsewhere [5, 7]. The study was ac-
tive for 178 days, and the median duration of an individual’s
participation was 171 days (interquartile range [IQR], 163–
176 days). Based on the frequency of nasopharyngeal swab
specimen collection, we expected 20 868 specimens from the
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493 individuals for the period they were under active follow-up.
A total of 16 928 swab specimens were collected, representing a
sampling compliance of 81.1%. Only 2% of individuals in the
study (10 of 493) were never sampled. The missed sampling
was mainly due to refusal of swabbing or when the individuals
were away during home visits, as previously reported [5, 7]. Of
the 483 individuals with at least 1 sample collected, the median
number of nasopharyngeal swab specimens collected was 41
(IQR, 30–44).
RSV Infection Detections
Of the 16 928 samples tested, RSV was detected in 537 (3.2%),
of whom 231 (43.0%) had infection with RSV group A alone,
287 (53.4%) had infection with group B alone, and 19 (3.5%)
had coinfection with groups A and B. The 2 RSV groups cocir-
culated with peak occurrence in March through May 2010 [7].
Of the 537 RSV-positive specimens, 229 (42.6%) were collected
when the individuals had concurrent symptoms of ARD, while
of the 16 391 RSV-negative specimens, 3335 (20.3%) were from
individuals with concurrent ARD symptoms (P <.0001, by the
χ2 test). Of the 483 individuals sampled, 179 (37.1%) had at
least 1 RSV infection episode, of these, 83 (46.4%) were male,
and the median age at infection was 6.5 years (IQR, 2.4–14.5
years; Table 1). One or more RSV infection episodes were iden-
tiﬁed in 40 of 47 households (85.1%).
RSV Infection Episodes
A total of 205 RSV infection episodes were determined in the
179 infected individuals: 155 individuals had 1 episode, 22
had 2 episodes, and 2 had 3 episodes. RSV group A was identi-
ﬁed in 81 infection episodes and RSV group B in 110, while 14
episodes had both RSV group A and B. Concurrent ARD symp-
toms were observed in 119 infection episodes (58.0%). The
main ARD symptoms observed were running or blocked nose
(117 episodes [98.3%]) and cough (89 [74.8%]). Difﬁculty
breathing was uncommon (6 episodes [5.0%]). Fever (reported
or measured; deﬁned as a axillary temperature of >38.0°C) was
documented in 17 (14.3%) of the symptomatic episodes. Of
those individuals with symptomatic episodes, 19 (16.0%) sought
medical care at a health facility, but none was hospitalized.
Predictors of Asymptomatic RSV Infection Episodes
Of the 205 RSV infection episodes, 86 (42.0%) were asymptom-
atic. For the symptomatic episodes, 41 (34.5%) had symptom
onset after virus was detected, with a median interval from
virus detection to the start of symptoms (ie, at the next 2 sam-
pling times) of 4 days (IQR, 3–6 days).
Age at infection, duration of infection episode, household
size, peak viral load, prevalence of concurrent RSV infections
within the household, infection by RSV group B, and prior
hRV infections were independent predictors of asymptomat-
ic RSV infection episodes (Table 2, Figures 1 and 2, and
Supplementary Table 2). The association of age in years and
odds of asymptomatic infections was nonlinear (quadratic),
with an initial increase of 20% per year (adjusted odds ratio
[aOR], 1.20; 95% conﬁdence interval [CI], 1.09–1.33) but di-
minishing by 0.002% per age squared (aOR, 0.998; 95% CI,
.996–.999). Individuals with RSV group B infections were 2
times more likely to be asymptomatic than those with group
Table 1. Prevalence of Asymptomatic Respiratory Syncytial
Virus (RSV) Infection Episodes, by Various Characteristics
Among 483 Individuals in a Prospective Household Study in
Rural Kenya
Characteristic
Evaluated
Subjects,
No.
Asymptomatic
Episode,
P Valuesa,bNo. (%)
Age at infection, y
0 to <1 33 3 (9.1) <.0001b
1 to <5 52 9 (17.3)
5 to <15 73 38 (52.1)
15 to <40 38 29 (76.3)
≥40 9 7 (77.8)
Sex
Female 116 58 (50.0) .008
Male 89 28 (31.5)
Detection of other respiratory viruses during the RSV infection
episode
None 124 62 (50.0) Reference
Adenovirus 23 10 (43.5) .566
Human coronavirus 17 6 (35.3) .255
Human rhinovirus 19 3 (15.8) .005
Mixed viruses (≥2) 22 5 (22.7) .018
During an RSV outbreak in household
No 42 26 (61.9) .003
Yes 163 60 (36.8)
Participant in school
No 137 46 (33.6) .001
Yes 68 40 (58.8)
Order of the individual infection episode
First 179 72 (40.2) .188
Secondc 26 14 (53.9)
Infecting RSV group(s)
Group A 81 34 (42.0) Reference
Group B 110 50 (45.5) .771
Groups A and B 14 2 (14.3) .072
Minimum Ct value during the infection episode
<20 40 4 (10.0) <.0001b
20–<25 76 24 (31.6)
25–<30 52 32 (61.5)
30–<35 37 26 (70.3)
Abbreviation: Ct, cycle threshold.
a For comparison of the percentages of asymptomatic episodes.
b By the nonparametric test for trend applies for age groups and minimum Ct
value categories. The rest of the P values are from chi-square test.
c Includes the second and the third repeat RSV infections per individual.
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A infections (aOR, 2.40; 95% CI, .998–5.75). The odds of an
asymptomatic episode declined by 35% for every 10-fold in-
crease in the peak viral load (aOR, 0.65; 95% CI, .46–.91).
RSV infection episodes linked to an hRV infection in the pre-
ceding 14 days were less likely to be asymptomatic than those
with no prior detections of hRV infection (aOR, 0.31; 95%
CI, .12–.83). Prior AdV or hCoV infections or any concurrent
virus infection were not signiﬁcant predictors of asymptomatic
RSV infection episodes (Supplementary Table 2). For every 1%
increase in the number of individuals with concurrent RSV in-
fection in a household, the odds of asymptomatic infections de-
clined by 2% (aOR, 0.98; 95% CI, .96–1.00), while for a unit
increase in household size, the odds of asymptomatic episodes
increased by 7% (aOR, 1.07; 95% CI, 1.02–1.13). The associa-
tion with household size was not statistically signiﬁcant after ex-
cluding the largest household (n = 37 members), whose 15 RSV
group A–infected members (60% of the household total) were
asymptomatic (Supplementary, Table 3). This household was
atypical in composition and size (with 12 and 8 children aged
<5 years and 5–15 years, respectively). The risk of clinical RSV
infection did not differ by sex after adjustment for potential
confounders. No interactions were identiﬁed.
Role of Symptomatic Status in Transmission of RSV Infections in
Households
Of the 205 RSV infection episodes, 84 (41.0%) were index cases.
Thirty-seven index cases (44.0%) were asymptomatic. Within-
household spread of RSV infection occurred in 10 asymptom-
atic index cases (27.0%), compared with 29 symptomatic index
Table 2. Predictors of Asymptomatic Episodes of Respiratory
Syncytial Virus (RSV) Infection From a Rural Kenyan Prospective
Household Study
Predictor
Adjusted OR
(95% CI)
P
Value
Age
Per y 1.20 (1.09–1.33) <.001
Per y squared 0.998 (.996–.999) .011
Household size, per unit size 1.07 (1.02–1.13) .003
Duration of RSV shedding, per d 0.90 (.82–.98) .010
Virus load, per unit log10 AU 0.65 (.46–.91) .001
Infecting RSV group
Group A 1.00 (reference)
Group B 2.40 (.998–5.745) .050
Percentage of individuals in
household infected, per 1%
increase
0.98 (.958–.999) .042
Detection of hRV during 14 d before
RSV episode
No hRV 1.00 (reference)
hRV 0.32 (.12–.83) .020
Abbreviations: AU, arbitrary units; CI, confidence interval; hRV, human
rhinovirus; OR, odds ratio.
Figure 1. Proportion of asymptomatic episodes of respiratory syncytial virus (RSV) infection in a household cohort study in Kenya, by age in years (A),
shedding duration (B), minimum cycle threshold (Ct) values (C), and percentage of individuals with concurrent RSV infection in the household (D). Data are
mean proportions (95% confidence intervals). Numbers of episodes per category appear above each bar.
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cases (61.7%; P<.002, by the χ2 test). After accounting for differ-
ences in age and household size, the odds of RSV spread upon
introduction into the household was about 5 times in the symp-
tomatic index cases relative to asymptomatic cases (aOR, 4.73;
95%CI, 1.21–18.53; Table 3). The duration of RSV shedding was
longer in symptomatic index cases relative to that in asymptom-
atic index cases (mean, 13.3 days [95% CI, 10.67–15.89 days] vs
6.8 days [95% CI, 5.3–8.4 days]; P = .0001, by the 2-sided t test;
Figures 3 and 4 and Supplementary Figure 1). The correspond-
ing comparison of mean peak viral load was log10 5.1 AU (9%
CI, 4.7–5.5 AU) for the symptomatic index case, compared with
log10 3.7 AU (95% CI, 3.3–4.2 AU) for the asymptomatic index
cases (P<.0001, by the 2-sided t test). The risk of within-house-
hold spread was inﬂuenced by virus shedding duration and
peak viral load (aOR, 1.21 [95% CI, 1.06–1.37] and 2.24 [95%
CI, 1.21–4.2], respectively). No effect modiﬁcation between
shedding duration and load was observed (P = .9083 for inter-
action, by the likelihood ratio test) on the odds of within-house-
hold spread.
DISCUSSION
We report the prevalence of asymptomatic RSV infections from
a study following 47 households with 493 individuals over the
26 weeks of an RSV epidemic. Nasopharyngeal swab specimens
were collected twice weekly regardless of symptoms and
screened for a range of respiratory viruses, including RSV.
Over 40% of the 205 RSV infection episodes were asymptomat-
ic. The probability of symptomless RSV infection increased with
age, peaking at about 40 years, and declined in older ages (Sup-
plementary Figure 2). This accords with published observations
that the risk of severe disease from RSV infection decreases with
age [14–17] and increases in elderly individuals [18]. Evidence
from experimental challenge and epidemiological studies also
support these observations and provide possible mechanisms
Figure 2. Proportion of asymptomatic respiratory syncytial virus (RSV) infection episodes in a household cohort study in Kenya, by age in years, stratified
by shedding duration (A), minimum threshold cycle (Ct) value (B), presence of other individuals with concurrent RSV infection in the household (C), and
infecting RSV group (D). Numbers of episodes per category appear above each bar.
Table 3. Multilevel Mixed Effects Logistic Regression Analysis
of Respiratory Syncytial Virus Spread Within Households
Predictor Adjusted ORa (95% CI) P Value
Clinical status
No ARD 1 (reference)
ARD 4.73 (1.21–18.53) .026
Duration, per d 1.21 (1.06–1.37) .005
Viral load, per unit log10 AU 2.24 (1.21–4.17) .011
Abbreviations: ARD, acute respiratory disease; AU, arbitrary unit; CI,
confidence interval; OR, odds ratio.
a Values adjusted for age and household sizes.
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[9, 16, 19, 20]. An experimental study using RSV A2 strain in
young adult volunteers, together with infection being deter-
mined by virus isolation, reported a greater risk of infection
in individuals administered a high RSV inoculum, compared
with those administered a low dose (57% vs 36%), with asymp-
tomatic infections occurring in 63% and 40% of the infections,
respectively [19]; individuals who were infected had statistically
lower serum neutralizing antibody titers than uninfected indi-
viduals. In another experimental infection study involving 13
adult volunteers, with low neutralizing antibody titers, 12 had
detectable viral shedding and respiratory illness when adminis-
tered a high dose of RSVA2 inoculum [19]. Even though these
experiments used a prototype virus, rather than the wild-type
virus as in the current study, their ﬁndings suggest that acquired
immunity against RSV and physiological development of the
airways could play an important role in reducing the severity
of RSV-associated respiratory disease. Serological studies show
that antibody produced during RSV infection in young children
and elderly individuals is ineffective and associated with an in-
appropriate cytokine response and excess inﬂammation of the
airways [21], partly explaining the increased disease severity
in these age groups. RSV has been identiﬁed as an important
pathogen in older ages [22].
In a US family study by Hall et al that used a similar intensive
specimen collection regimen but detection by virus culture [2],
the prevalence of asymptomatic infection was low in families
exposed to RSV, which could be due to exposure to large inoc-
ulum from close contacts within the household. Only 5% of in-
fected individuals (2 of 39) had asymptomatic infection in the
US study. In a study of infants admitted with RSV to intensive
Figure 3. Association of respiratory syncytial virus (RSV) shedding duration (A) and peak load (B) with age in years among index cases in a household
cohort study in Kenya, stratified by clinical status. Acute respiratory disease (ARD) presence is denoted by red, ARD absence is denoted by blue, and cases
linked with virus spread are denoted by green. Abbreviation: AU, arbitrary units.
Figure 4. Duration (A) and peak load (B) of respiratory syncytial virus (RSV)
shedding in a household cohort study in Kenya, by clinical and household trans-
mission status. Acute respiratory disease (ARD) presence is denoted by red,
ARD absence is denoted by blue, and cases linked with virus spread are denot-
ed by green. Data are mean values (95% confidence intervals). P values were
calculated by 2-sided t tests comparing the mean values in index cases linked
with spread, stratified by clinical status. Abbreviation: AU, arbitrary units.
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care units, Crowcroft et al reported a prevalence of asymptom-
atic infection, as determined by PCR of pernasal swabs, of 48%
and 49% in the siblings and parents, respectively [23]. This sug-
gests that the study by Hall et al [2]might have missed subclin-
ical infections, particularly in older children and adults, owing
to reduced sensitivity of the viral culture in asymptomatic cases.
Alternatively, it is possible that in the present study, virus shed
from asymptomatic cases was not viable, resulting in an overes-
timation of subclinical infections. We show that infection epi-
sodes with low peak viral load or absence of concurrent RSV
infections in the household were associated with a reduced
risk of ARD. In general, it appears that asymptomatic RSV in-
fections are likely in individuals with previous exposure to RSV
(and with concomitant high levels of neutralizing antibodies),
such as older children and young adults [19].
Our ﬁndings add to the debate on the differential virulence of
RSV strains [24]. We found that group B RSV infections were
associated with higher risk of asymptomatic infection than
group A infections. This association had a stronger statistical
signiﬁcance when we excluded the atypical household (Supple-
mentary Table 3). The consistency of this ﬁnding with results
from published studies [25, 26] supports the hypothesis that
group B RSV infections are less severe than group A RSV infec-
tions in the community. Walsh et al observed that hospitalized
infants without underlying medical conditions who were infect-
ed with RSV group B rarely required respiratory support, com-
pared with those infected with group A (1% vs 12%) [25]. The
individual attack rates for groups A and B were similar (48.0%
and 56.4%, respectively), and the preceding epidemic was pre-
dominated by group A (Nokes et al, unpublished data). This
precludes that any differential effect of infection severity was
due to dominance of one group in the community. However,
other studies have reported conﬂicting results on the relation-
ship of RSV groups to disease severity [27–31]. Most of these
are hospital studies that used less sensitive virus detection meth-
ods (ie, viral culture and immunoﬂuorescence techniques) or
collected specimens upon report of respiratory illness.
We have previously reported an association of the presence of
other respiratory viruses (hRV, AdV, and hCoV) just prior to
RSV infection with reduced shedding duration and an increase
in shedding duration if these respiratory viruses are codetected
with RSV [5]. In the current study, hRV infection <14 days be-
fore the start of RSV infection was associated with a reduced
risk of asymptomatic infection. However, no signiﬁcant associ-
ation was observed between the presence of other respiratory vi-
ruses (AdV and hCoV) before or during the RSV episode and
the risk of symptomless RSV infection. This association be-
tween RSV and hRV infections is more likely to be mediated
through nonspeciﬁc cross-reactivity of innate immunity, such
as the physiological status of respiratory epithelia following
virus infection. Additional investigation is required to explore
these effects.
About one fourth (27%) of the asymptomatic index cases were
linked with household spread, compared with 61% for the symp-
tomatic index cases. We observed a strong positive correlation be-
tween the markers of RSV shedding (ie, duration and viral load)
over the infection period (Figure 4) and the probability of spread.
Longer RSV infection episodes or those with a higher peak viral
load were more likely to be symptomatic than their counterparts.
The presence of symptoms and correlates of the amount of virus
shedding (ie, duration and load) were independently associated
with the risk of within-household spread among the index
cases, after adjustment for age and household size. These ﬁndings
taken together indicate that symptomatic individuals were more
infectious and, thus, better transmitters than those without
symptoms. The correlation of ARD and the amount of virus
shedding suggests that vaccines that decrease viral shedding se-
verity upon exposure to RSV, even if they do not reduce the
risk of infection itself, could diminish virus transmission in the
population. However, 34% of the symptomatic RSV episodes
had the illness appear on average 4 days after ﬁrst detection of
the virus. If individuals change their behavior as a result of symp-
toms, such as by reducing their contacts, the period of shedding
before symptoms appear or the prevalence of asymptomatic in-
fections might have an accentuated role in transmission of RSV
in the population. Furthermore, the high frequency of asymp-
tomatic RSV cases observed in this study, coupled with the non-
negligible infectivity of the asymptomatic state, suggests that
these individuals could play an important role in the transmis-
sion of RSV in a population.
One limitation of the study relates to the use of a Ct value of
≤35 to deﬁne virus-positive samples. The detection of RNA
does not necessarily correlate with the presence of infectious
virus. In the future, the Ct value associated with the potential
to infect must be established, and assessment of the viability (in-
fectiousness) of the viruses detected in asymptomatic infections
is warranted. However, one fourth of the index cases linked with
household spread were without symptoms in the current study.
Despite the intensive sampling regimen, RSV infections with
low viral load or short duration of shedding (<3 days), especially
the asymptomatic cases, might have been missed. Our estimate
of the prevalence of asymptomatic infections might be an un-
derestimate, even though use of sensitive PCR screening meth-
ods might have diminished the detection bias.
In conclusion, the high prevalence of asymptomatic RSV infec-
tion highlights the importance of detecting respiratory viruses, re-
gardless of illness status, to gain a nearly full understanding on the
virus epidemiology in the community. Our results show that a sig-
niﬁcant proportion of RSV infections are asymptomatic; thus, the
amount of the virus circulating in the community would be un-
derestimated if the contribution of asymptomatic infections is
overlooked. We provide empirical data that will be useful in devel-
oping a realistic RSV transmission model for assessing the impact
of RSV vaccines and other interventions on viral circulation.
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